Jump to content
RemedySpot.com

Researchers produce anti-carcinogenic protein

Rate this topic


Guest guest

Recommended Posts

Researchers produce anti-carcinogenic protein

www.chinaview.cn 2006-09-14 07:12:23

ISLAMABAD, Sept. 13 (Xinhua) -- Pakistani researchers have successfully

produced an antiviral and anti-cancerous recombinant protein Human

Interferon Alpha2B, the state-run APP news agency reported on Wednesday.

A research team in the prestigious University of Punjab, have adopted

the cloning technique to develop the recombinant protein, generally used to

treat critical illnesses like hepatitis, said the APP report.

The development of the protein would cut down the cost of hepatitis

treatment in Pakistan, which has so far been very difficult for lower income

people in the country, said Nasir Mahmood, a key member of the team.

Being sure that this is the first time Pakistani researchers have

produced anti-cancerous protein locally, the research team leader Professor

Dr. Naeem Rashid said they wanted the product to be commercialized to

benefit local patients of hepatitis by offering the antidote at affordable

price, according to the report.

http://news.xinhuanet.com/english/2006-09/14/content_5088392.htm?rss=1

Editor: Pliny Han

_________________________________________________________________

Call friends with PC-to-PC calling -- FREE

http://imagine-msn.com/messenger/launch80/default.aspx?locale=en-us & source=wlmai\

ltagline

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...